AI Multi-Horizon Analysis
Intraday momentum is bearish; price near session lows with oversold conditions suggests possible short-term bounce but overall downward bias.
Short-term trend remains bearish with oversold conditions suggesting potential for a bounce, but technical signals like MACD and support levels favor downward continuation.
Long-term trend is still technically bullish but overbought signals and deteriorating fundamentals pose risks. A sustained move below support could shift outlook.
Tesla shows signs of fundamental and technical stress with revenue contraction, margin compression, insider net selling, and rising dilution. Short-term oversold conditions suggest a potential bounce, but the long-term trend remains bearish unless key support levels hold.
Detailed AI Fundamental Analysis
TSLA (Tesla, Inc.) – Comprehensive Fundamental Briefing
Date: Based on data through 2026-05-12
Price: $430.31 (closed)
Session Range: $364.02 – $449.16
Market Status: Closed
Business Snapshot
Tesla, Inc. is a vertically integrated energy and automotive company headquartered in Austin, Texas. The company designs, manufactures, and sells electric vehicles (EVs), energy generation and storage systems, and related software and services. Tesla also operates its own network of Supercharger stations and sells regulatory credits to other automakers.
As of the latest filing (Q1 2026), Tesla had 3.755 billion shares outstanding, up from 3.224 billion in Q2 2025 — a 16.5% increase in the share count over nine months, primarily driven by the massive April 2026 stock award to Elon Musk (96 million shares).
Financial Trends (4-Period Trajectory)
Revenue Trajectory
| Period | Revenue | Change vs Prior Period |
|---|---|---|
| Q2 2025 | $22.50B | — |
| Q3 2025 | $28.10B | +24.9% QoQ |
| FY 2025 (Q4) | $94.83B (annual) | — |
| Q1 2026 | $22.39B | -20.3% vs Q3 2025 |
Trend: Revenue is decelerating sharply. After a strong Q3 2025 ($28.1B), Q1 2026 revenue fell to $22.39B — the lowest quarterly figure in the trailing four quarters. The Q1 print is also below Q2 2025 levels, indicating a contraction in the core business.
Gross Margin Trajectory
| Period | Gross Margin | Change |
|---|---|---|
| Q2 2025 | 17.24% | — |
| Q3 2025 | 17.99% | +75 bps |
| FY 2025 | 18.03% | +4 bps (annual) |
| Q1 2026 | 21.08% | +305 bps vs FY25 avg |
Trend: Gross margins are inflecting upward — a rare bright spot. Q1 2026 gross margin of 21.08% is the highest in the trailing four periods, suggesting improved cost management or a favorable product mix shift. This is a positive divergence from the revenue decline.
Operating & Net Margin Trajectory
| Period | Operating Margin | Net Margin |
|---|---|---|
| Q2 2025 | 4.10% | 5.21% |
| Q3 2025 | 5.78% | 4.89% |
| FY 2025 | 4.59% | 4.00% |
| Q1 2026 | 4.20% | 2.13% |
Trend: Operating margin held relatively steady at ~4.2% in Q1 2026, but net margin collapsed from 5.21% (Q2 2025) to just 2.13% (Q1 2026). This implies higher interest expense, tax burden, or non-operating charges are compressing bottom-line profitability despite the gross margin improvement.
Free Cash Flow Trajectory
| Period | FCF | Change |
|---|---|---|
| Q2 2025 | $0.81B | — |
| Q3 2025 | $4.80B | +493% QoQ |
| FY 2025 | $6.22B (annual) | — |
| Q1 2026 | $1.44B | -70% vs Q3 2025 |
Trend: FCF is decelerating after a massive Q3 2025 spike. Q1 2026 FCF of $1.44B is still positive but down significantly from the $4.80B in Q3. The gap between operating cash flow ($3.94B) and capex ($2.49B) is narrowing, suggesting capital intensity is rising.
Balance Sheet Trajectory
| Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Trend |
|---|---|---|---|---|---|
| Total Assets | $128.6B | $133.7B | $137.8B | $143.7B | Accelerating (+11.7% in 9 months) |
| Total Liabilities | $50.5B | $53.0B | $54.9B | $58.9B | Accelerating (+16.6%) |
| Shareholders' Equity | $77.3B | $80.0B | $82.1B | $84.1B | Steady growth (+8.8%) |
| Cash & Equivalents | $15.6B | $18.3B | $16.5B | $16.6B | Flat |
| Inventory | $14.6B | $12.3B | $12.4B | $14.4B | Rebuilding |
| Shares Outstanding | 3.224B | 3.324B | 3.751B | 3.755B | Diluting (+16.5% in 9 months) |
Trend: The balance sheet is expanding rapidly — assets grew $15.1B in nine months — but liabilities are growing faster (+16.6% vs +11.7% for assets). Cash is essentially flat, meaning the growth is being funded by debt/liabilities and equity dilution, not organic cash generation. Inventory is reaccumulating after being drawn down in Q3/Q4 2025, which could signal slowing demand.
Working Capital & Current Ratio
| Period | Current Ratio | Working Capital |
|---|---|---|
| Q2 2025 | 2.04 | $31.1B |
| Q3 2025 | 2.07 | $33.4B |
| Q4 2025 | 2.16 | $36.9B |
| Q1 2026 | 2.04 | $35.6B |
Trend: The current ratio peaked at 2.16 in Q4 2025 and has reverted to 2.04 — the same level as Q2 2025. Working capital is still high but declining sequentially, suggesting liquidity is tightening slightly.
Financial Health (Interpretation)
Summary: Tesla is in a transitional period — the top-line growth story has stalled, but cost controls are improving gross margins. The divergence between expanding gross margins and collapsing net margins is concerning and warrants monitoring.
Key observations:
- Revenue contraction is the most alarming signal. Q1 2026 revenue of $22.4B is below Q2 2025 levels — a full year of no growth.
- Gross margin improvement (+305 bps to 21.08%) shows Tesla is getting more efficient in production, possibly due to lower raw material costs or better factory utilization.
- Net margin compression (from 5.21% to 2.13%) suggests non-operating costs are eating into profits — could be interest on the growing debt load, one-time charges, or higher tax provisioning.
- FCF is positive but weakening — $1.44B in Q1 2026 is still healthy, but the trajectory from $4.80B in Q3 2025 is concerning.
- Share dilution is accelerating — 16.5% more shares outstanding in nine months. The 96 million-share grant to Elon Musk on April 21, 2026 (post-period) will further dilute existing holders.
- Inventory is building — up $2.0B from Q4 2025 to Q1 2026, which could indicate demand softening or production outpacing deliveries.
Overall: Financially stable but decelerating. The company is not in distress (positive FCF, $16.6B cash, current ratio >2), but the growth narrative that drove the stock to $498 is fading. The business is transitioning from hypergrowth to a mature, capital-intensive industrial company.
Insider Activity
Sentiment Overview (Feb 11 – May 12, 2026)
- Sentiment Score: Neutral (-9)
- Total Buys: $2.22M (5 transactions)
- Total Sells: $30.85M (45 transactions)
- Net Insider Flow: -$28.63M (strongly bearish)
Notable Transactions
| Date | Insider | Action | Value | Notes |
|---|---|---|---|---|
| 2026-04-30 | Wilson-Thompson Kathleen | Buy | $613.8K | 40,948 shares @ $14.99 (likely option exercise) |
| 2026-04-30 | Wilson-Thompson Kathleen | Sell | $10.3M | 27,449 shares @ $369-$384 (immediate sale of exercised options) |
| 2026-04-21 | Elon Musk | Sell | $0.00 | 96,000,000 shares — stock award, no cash transaction |
Interpretation: The insider activity is overwhelmingly bearish on a dollar basis. The only "buy" was an option exercise by director Wilson-Thompson — she bought at $14.99 and immediately sold at market prices (~$370+), which is not a vote of confidence but rather a standard compensation monetization. Elon Musk's 96 million-share award (worth ~$35B at current prices) is a massive dilution event that will pressure the stock.
Key takeaway: Insiders are net sellers by a wide margin. No insider has made an open-market purchase at current elevated prices. The only buying activity is option exercises that are immediately sold.
Multi-Timeframe Technical Context
Ultra-Short (1m, 5m) — Minutes to Hours
- 1m: Price is at $430.31, near session lows. RSI_14 at 43.16 (neutral-bearish). MACD is negative but signal line is above (-0.2613 vs -0.2408), suggesting a potential bullish crossover on the 1m. Price is hugging the lower Bollinger Band ($430.17), indicating oversold pressure.
- 5m: RSI_14 at 21.06 — deeply oversold. MACD is negative and widening (-0.5064 vs signal -0.2885). Price is below all EMAs (12/26/50) and below the 200-bar SMA. Volume is 2.85x normal on the 5m, suggesting panic selling.
Verdict: Ultra-short is oversold and extended — a bounce is technically probable, but the trend is decisively down.
Short-Term (15m, 1H) — Hours to Days
- 15m: RSI_14 at 30.98 (oversold), but RSI_21 at 52.82 (neutral). MACD is negative but flattening. Price is below the lower Bollinger Band ($430.35 vs $430.35), which is a rare condition that often precedes a snap-back.
- 1H: RSI_14 at 33.34, RSI_21 at 32.86 — both oversold. MACD is negative and the signal line is above (0.8635 vs -0.098), a bearish configuration. Price is below the 20- and 50-bar SMAs but well above the 200-bar SMA ($396.40). The 200-bar SMA on the 1H is a major support zone. Volume is ~4.6% of normal — very thin, typical of after-hours.
Verdict: Short-term is oversold with potential for a dead-cat bounce, but the 1H MACD is bearish and the price is in no-man's land between the 50-SMA ($429.72) and the 200-SMA ($396.40).
Long-Term (1D) — Weeks to Months
- 1D: RSI_14 at 70.04, RSI_21 at 71.99 — overbought on the daily. MACD is positive and bullish (12.86 vs signal 6.19). Price is above all EMAs (12/26/50) and above the 200-day SMA ($405.67). The stock is trading at the upper Bollinger Band ($435.26), which typically acts as resistance.
- Volume: Today's volume (60.6M) is near the 20-day average (65.0M) — no panic volume on the daily.
Verdict: Long-term trend is still bullish (price above all major moving averages, MACD positive), but the RSI is flashing overbought and the stock is at the upper Bollinger Band. The daily chart suggests a topping process, not a crash.
Key Technical Takeaway
- Shorter timeframes are screaming oversold — a bounce is likely.
- Longer timeframes are overbought — the bounce may be sold into.
- The 1H 200-SMA at $396.40 is the critical support level. A break below that would be a major technical deterioration.
Bull / Bear Cases
Short-Term Bull Case (Hours to Days)
- Oversold bounce: 5m RSI at 21 and 15m RSI at 31 suggest a technical snap-back is imminent. The 1m MACD is about to cross bullish.
- Support at $396: The 1H 200-SMA at $396.40 is a major support level that has held the entire uptrend. A bounce from that area could propel price back to $435-$449.
- Insider exercise floor: Wilson-Thompson's option exercise at $14.99 and immediate sale at $369-$384 suggests insiders see fair value in the $370-$380 range — a potential price floor.
Short-Term Bear Case (Hours to Days)
- Massive dilution overhang: The 96 million-share Musk award (April 21) will likely be sold in the open market over time, creating constant selling pressure.
- Insider selling: $30.85M in insider sales in the last month, with no open-market buys — insiders are voting with their feet.
- Technical breakdown: Price is below all short-term EMAs on the 5m and 15m. If $430 (lower BB on 15m) breaks, the next stop is $422 (session low) then $396.
- Net margin compression: From 5.21% to 2.13% in three quarters — profitability is eroding.
Long-Term Bull Case (Weeks to Months)
- Gross margin inflection: 21.08% gross margin is the highest in four quarters — if this trend continues, operating leverage could drive earnings higher even on flat revenue.
- Cash pile: $16.6B in cash provides a war chest for R&D, capacity expansion, or buybacks (though the latter seems unlikely given dilution).
- Energy business: Not broken out in the financials, but Tesla's energy storage segment is a growth driver that could re-rate the stock.
- Technical support: The 200-day SMA at $405.67 and the 1H 200-SMA at $396.40 are still intact — the long-term uptrend is not broken.
…
